Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps
NANot yet recruitingINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
October 1, 2025
Primary Completion Date
January 31, 2028
Study Completion Date
August 1, 2028
Conditions
Asthma BronchialeChronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Interventions
DRUG
Tezepelumab
injection with Tezepelumab every 4 weeks
Trial Locations (1)
A-1090
Medical University of Vienna, Vienna
All Listed Sponsors
lead
Medical University of Vienna
OTHER
NCT07046117 - Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps | Biotech Hunter | Biotech Hunter